Enveric Biosciences ENVB Stock
Enveric Biosciences Price Chart
Enveric Biosciences ENVB Financial and Trading Overview
| Enveric Biosciences stock price | 1.01 USD |
| Previous Close | 3.64 USD |
| Open | 3.56 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1200 |
| Day's Range | 3.56 - 3.95 USD |
| 52 Week Range | 1.3 - 18.5 USD |
| Volume | 91.77K USD |
| Avg. Volume | 3.55M USD |
| Market Cap | 8.02M USD |
| Beta (5Y Monthly) | 0.462181 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.09 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | April 23, 2008 |
| 1y Target Est | 7 USD |
ENVB Valuation Measures
| Enterprise Value | -3951514 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.38599998 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.7709207 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.201 |
Trading Information
Enveric Biosciences Stock Price History
| Beta (5Y Monthly) | 0.462181 |
| 52-Week Change | -58.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 18.5 USD |
| 52 Week Low | 1.3 USD |
| 50-Day Moving Average | 2.55 USD |
| 200-Day Moving Average | 2.95 USD |
ENVB Share Statistics
| Avg. Volume (3 month) | 3.55M USD |
| Avg. Daily Volume (10-Days) | 181.84K USD |
| Shares Outstanding | 2.08M |
| Float | 1.95M |
| Short Ratio | 0.03 |
| % Held by Insiders | 12.59% |
| % Held by Institutions | 8.42% |
| Shares Short | 347.29K |
| Short % of Float | 16.85% |
| Short % of Shares Outstanding | 16.71% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.11% |
| Return on Equity (ttm) | -103.88% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -19681146 USD |
| Net Income Avi to Common (ttm) | -19077156 USD |
| Diluted EPS (ttm) | -9.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.56M USD |
| Total Cash Per Share (mrq) | 6.04 USD |
| Total Debt (mrq) | 37.04K USD |
| Total Debt/Equity (mrq) | 0.33 USD |
| Current Ratio (mrq) | 4.154 |
| Book Value Per Share (mrq) | 5.007 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17734792 USD |
| Levered Free Cash Flow (ttm) | -9524717 USD |
Profile of Enveric Biosciences
| Country | United States |
| State | FL |
| City | Naples |
| Address | 4851 Tamiami Trail N |
| ZIP | 34103 |
| Phone | (239) 302-1707 |
| Website | https://www.enveric.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 25 |
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead program is EB-373, an active metabolite of psilocybin, which is in Phase 1 clinical trials for the treatment of anxiety disorders; EVM-301 for treating mental health; and EV104 CBD + Celecoxib conjugate for treating osteoarthritis. The company also developing cannabinoid-infused topical product for the treatment of radiodermatitis; and cannabinoid and COX-2 inhibitor conjugation that is in pre-clinical stage for the treatment of OA/acute pain. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Q&A For Enveric Biosciences Stock
What is a current ENVB stock price?
Enveric Biosciences ENVB stock price today per share is 1.01 USD.
How to purchase Enveric Biosciences stock?
You can buy ENVB shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enveric Biosciences?
The stock symbol or ticker of Enveric Biosciences is ENVB.
Which industry does the Enveric Biosciences company belong to?
The Enveric Biosciences industry is Biotechnology.
How many shares does Enveric Biosciences have in circulation?
The max supply of Enveric Biosciences shares is 7.29M.
What is Enveric Biosciences Price to Earnings Ratio (PE Ratio)?
Enveric Biosciences PE Ratio is now.
What was Enveric Biosciences earnings per share over the trailing 12 months (TTM)?
Enveric Biosciences EPS is -8.09 USD over the trailing 12 months.
Which sector does the Enveric Biosciences company belong to?
The Enveric Biosciences sector is Healthcare.
Enveric Biosciences ENVB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}